Summary:
We are currently recruiting participants for a clinical research study to evaluate the effectiveness of an investigational medication compared with daily insulin degludec in type 2 diabetics currently on a basal (long-acting) insulin and not on a bolus (mealtime/fast-acting) insulin.
Qualified Participants Must:
• 18 years of age or older
•
Have a diagnosis of type 2 diabetes
•
Have an HbA1c value of 6.5% to 10.0%, inclusive
•
Body Mass Index (BMI) less than or equal to 45kg/m2
•
Additional qualification criteria exist
Qualified Participants May Receive:
- Reimbursement for time and travel
- You are provided study-related care and study medicine at no cost (no health insurance required)